Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy — two days after it announced the new drug and one day after the Food and Drug ...
The online telehealth company pulls the plug on its compound version of Novo Nordisk's Wegovy drug in the wake of FDA commissioner's warning ...
Hims & Hers said it would stop selling its new compounded semaglutide pill after "constructive conversations with stakeholders across the industry." ...
Health officials warn weight-loss injections could cause sudden blindness as new safety labels added
NAION has been listed as a rare potential side effect of semaglutide treatments such as Ozempic, Wegovy and Rybelsus ...
Wall Street's major averages closed significantly higher on Friday, with the Dow Jones (DJI) topping 50,000 and ending at a record after several days of technology-led selloff. The Dow Jones (DJI) ...
Novo Nordisk threatens legal action against Hims & Hers for "duping" public with cheap compounds of its popular weight-loss ...
Novo Nordisk (NVO) Faces Pricing Pressure While Defending Wegovy Franchise and Advancing Oral GLP-1s
Novo Nordisk A/S (NYSE:NVO) is one of the best affordable long term stocks to buy according to hedge funds. On February 5, ...
GLP-1 injections, sold under brands like Ozempic, Wegovy, and Mounjaro, are used to lose weight and treat type 2 diabetes. People using these injections should be aware of the rare but real chance of ...
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results